Editorial
Focusing in on radiation induced brain injury
Translational Cancer Research
2014;
3
(2)
:112-115
.
(25 April 2014)
To AVoiD bleomycin from Hodgkin’s regimen?
Translational Cancer Research
2014;
3
(2)
:116-118
.
(25 April 2014)
Epidermal growth factor receptor: will it ever become a therapeutic target in ovarian cancer?
Translational Cancer Research
2014;
3
(2)
:119-123
.
(25 April 2014)
Original Article
Defining functional changes in the brain caused by targeted stereotaxic radiosurgery
Translational Cancer Research
2014;
3
(2)
:124-137
.
(25 April 2014)
Technical note: simultaneous 90Y and 99mTc-MAA injection for two-stage selective internal radiation therapy (SIRT) of liver metastases
Translational Cancer Research
2014;
3
(2)
:138-145
.
(25 April 2014)
Social factors, treatment, and survival in patients with advanced-stage non-small cell lung cancer
Translational Cancer Research
2014;
3
(2)
:146-151
.
(25 April 2014)
The incidence of second primary malignancies after gastrointestinal stromal tumor before and after the introduction of imatinib mesylate
Translational Cancer Research
2014;
3
(2)
:152-159
.
(25 April 2014)
KRAS and BRAF mutation frequencies in a series of Turkish colorectal cancer patients
Translational Cancer Research
2014;
3
(2)
:160-166
.
(25 April 2014)
Intraoperative Radiotherapy1
Intraoperative Radiotherapy with electrons
Translational Cancer Research
2014;
3
(2)
:167-174
.
(25 April 2014)
Brest experience in intraoperative radiotherapy for breast cancer
Translational Cancer Research
2014;
3
(2)
:175-179
.
(25 April 2014)
Disclosure:
1. The series “Intraoperative Radiotherapy” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Frederik Wenz and Elena Sperk served as the unpaid Guest Editors for the series.
